Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price rose 1.8% during mid-day trading on Wednesday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares were traded during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Trading Up 1.8 %
The company has a debt-to-equity ratio of 0.52, a quick ratio of 9.41 and a current ratio of 9.74. The firm has a market capitalization of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22. The firm has a 50 day simple moving average of C$0.58 and a two-hundred day simple moving average of C$0.58.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Recommended Stories
- Five stocks we like better than Acasti Pharma
- How to Plot Fibonacci Price Inflection Levels
- Survey Reveals: America’s Most Coveted Businesses in 2024
- What is the Euro STOXX 50 Index?
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
